Pharmacy Report Archives - Page 8 of 148 - Becker's Hospital Review

5 pharmacy market trends | Medicaid drug spend up 46% as Rx volume stalls | Gene therapy co. reports stockout | Pfizer's Lyme vaccine heads to FDA | Lilly's next-gen GLP-1 boosts weight loss, A1C

Pharmacy market trends, gene therapy shortage and GLP-1 push top today’s news March 24, 2026 1. Inside the 2026 pharmacy market: 5 key trends Full story 2. 5 things to know about Medicaid drug spending: KFF Full story 3. Chief…

10 future blockbuster drugs to watch | Mount Sinai names CPO | TrumpRx's 57 drugs | 15 hospital med safety best practices | ASHP taps former Cleveland Clinic exec as CEO

Future blockbuster drugs, Mount Sinai CPO and TrumpRx expansion top today’s news March 23, 2026 1. 10 drugs poised to be global best-sellers in 2030 Full story 2. Mount Sinai names chief pharmacy officer Full story 3. Procurement blind spots…

8 new drugs in shortage | TrumpRx tops 50+ drugs with Mark Cuban backing | FDA clears higher-dose Wegovy, recalls 89K children's ibuprofen bottles | ASHP fills 3,872 residency spots

TrumpRx expansion, new drug shortages and Wegovy approval top today’s news March 19, 2026 1. 8 drugs in shortage Full story 2. Mark Cuban supports TrumpRx as platform scales to 50+ drugs Full story 3. Find case studies in pharmacies…

TrumpRx prices miss global low-cost mark | 6 drugmakers to know | HHS plans $200M cancer vaccine initiative | IRA linked to stronger med adherence | GLP-1s tied to lower SUD risk

TrumpRx price gap, HHS cancer vaccine push and new psoriasis pill top today’s news March 18, 2026 1. TrumpRx prices fail to match global low-cost promise Full story 2. 6 pharmaceutical companies to know | 2026 Full story 3. Procurement…

Cone CPO eyes systemwide pharmacy growth | 15 largest US pharmacies | FDA rejects eye drug candidate | 3 GLP-1 updates | Baptist pharmacy leader joins Prisma

Plus: HCA’s highest-earning executives. March 17, 2026 1. Not just 'cost cutting': How Cone Health is repositioning pharmacy Full story 2. Top 15 pharmacies by 2025 prescription revenue Full story 3. Hear 90+ pharmacy executives discuss cost, workforce & clinical…

US-Iran conflict threatens generic drug supply | Drug affordability worries hit new high | Lilly flags compounded GLP-1 risks | Clinicians divided on unproven autism drug | CMS advances 3rd Medicare drug round

Iran conflict risks generics, Medicare drug talks and medication affordability fears top today’s new March 16, 2026 1. US-Iran conflict threatens generic drug supply Full story 2. Drug affordability worries highest since 2018: KFF poll Full story 3. This is…

FDA debuts single adverse event system | Senate panel probes rare disease drug denials | How VCU Health preempted a pharmacy desert | 10 systems hiring pharmacy leaders | Pediatric HIV trials expanded

Senate FDA probe, safety platform launch, and pharmacy leader job openings top today’s news March 12, 2026 1. How VCU Health preempted a pharmacy desert Full story 2. Senate panel to probe FDA rare disease drug denials Full story 3.…

Pharmacy staffing gaps spur automation | FDA: Novo failed to report adverse events | Hospital drug costs up 13.6%: AHA | Pharmacists back printed Rx info bill | Memorial pharmacy leader joins Ascension

Pharmacy automation rises amid staffing gaps & FDA flags Novo reporting lapse. March 11, 2026 1. Pharmacy staffing gaps fuel automation surge Full story 2. Novo Nordisk failed to report adverse drug events: FDA Full story 3. Temple Health, Endeavor…

10 drugs poised to be top sellers | FDA eyes changes to biosimilar approvals | Inside a Md. school's new PharmD curriculum | Cancer drug pulled from US market | Amazon Pharmacy to sell Zepbound KwikPen

March 10, 2026 1. 10 drugs expected to lead US sales in 2026 Full story 2. Maryland pharmacy school edits PharmD curriculum to target workforce demands Full story 3. When pharmacies disappear, patients pay the price. Learn how to fight back…

Novo, Hims reach GLP-1 truce | FDA, states review plans for Canada drug imports | Pa. hospitals lose CVS 340B case | FDA vaccine chief to exit in April | U of Kentucky taps 2 pharmacy leaders

Novo-Hims GLP-1 deal, CVS 340B ruling and FDA drug pricing push top today’s news March 9, 2026 1. Novo, Hims strike GLP-1 deal after legal feud Full story 2. FDA, states review plans to import drugs from Canada Full story…